Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Completed 17Unknown 3Terminated 3Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2Genitourinary 1

Conditions

Breast Neoplasms 2Prostatic Neoplasms 1Pain 1Hot Flashes 1Chronic Disease 1

Interventions

Cyclophosphamide 391Carboplatin 344Gemcitabine 332pembrolizumab 331Cisplatin 328Paclitaxel 298Radiotherapy 297Docetaxel 287Bevacizumab 253Rituximab 234Capecitabine 224Nivolumab 222Dexamethasone 206Fluorouracil 190fludarabine 178Oxaliplatin 177Pemetrexed 153Doxorubicin 153Irinotecan 148Leucovorin 144Etoposide 144Cytarabine 134Cetuximab 130fludarabine phosphate 129Bortezomib 129Lenalidomide 126Filgrastim 120Erlotinib Hydrochloride 120Temozolomide 113Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Soybean Proteins × Clear all
NCT00354432 2021-09-28

Soy Protein/Effexor Hormone Therapy for Prostate Cancer

Wake Forest University Health Sciences

Phase 3 Terminated
120 enrolled 11 charts
Genitourinary

Prostatic Neoplasms, Hot Flashes

NCT01047774 2015-10-07

The Effect of Soy Protein on Post- Breast Cancer Surgery Pain

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase 2 Terminated
6 enrolled
Breast

Breast Neoplasms, Chronic Disease, Pain

NCT00036686 2012-09-24

Isoflavones in Treating Women Who Have Breast Cancer and Are Planning to Undergo Mastectomy or Lumpectomy

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Terminated
1 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡